Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, briefly discusses the promising role of pelabresib for the treatment of myelofibrosis (MF), and shares some insights into the ongoing Phase III MANIFEST-2 study (NCT04603495). This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
